Pharmacologic Stress Agents for Myocardial Perfusion Imaging

Clinical Pearl: Patient Preparation and Antidotes For both dipyridamole and adenosine, strict patient preparation is required. Patients must be NPO (nothing by mouth) for 4 hours and must avoid all caffeine and xanthine derivatives (such as theophylline or aminophylline). This is because caffeine blocks the $A_2$ receptors, which would render the stress test ineffective. If a patient experiences adverse effects, intravenous aminophylline serves as the antidote for both agents.

Inotropic Agents: Dobutamine

In contrast to the vasodilators mentioned above, dobutamine (Dobutrex®) is an inotropic agent. It does not work by dilating the vessels directly; instead, it selectively stimulates $\beta_1$ receptors in the heart.

This stimulation produces two primary effects:

1. Increased myocardial contractility.
2. Increased heart rate.

These actions increase the myocardial oxygen demand, which in turn triggers coronary vasodilation to meet that demand. Because it does not rely on the adenosine pathway, dobutamine is a useful alternative for patients with asthma.

Managing Side Effects and Adjuncts

Dobutamine can cause side effects such as increased blood pressure, palpitations, and chest pain. At high doses, it may even cause ventricular tachycardia or paroxysmal atrial fibrillation. These arrhythmias can be managed by terminating the infusion or administering intravenous $\beta$-blockers, such as esmolol or metoprolol.

Additionally, atropine—an anticholinergic muscarinic antagonist—is often used as an adjunct to dobutamine. By blocking acetylcholine receptors, atropine can help increase the heart rate to reach the target rate required for an adequate stress test.

Assessing Sympathetic Innervation with I-123 mIBG

Beyond perfusion, nuclear medicine can assess the functional integrity of the cardiac sympathetic nervous system using I-123 mIBG.

I-123 mIBG is a norepinephrine analog. Because it mimics norepinephrine, it serves as a tracer for sympathetic neuron integrity and function. This is particularly useful in patients with congestive heart failure, a condition characterized by the activation of cardiac sympathetic nerves.

Clinical Indications and Interpretation

The use of I-123 mIBG is specifically indicated for:

• Patients with New York Heart Association (NYHA) class II or III heart failure.
• Patients with a left ventricular ejection fraction (LVEF) $\le 35\%$.

The assessment relies on the Heart-to-Mediastinum (H/M) ratio of radioactivity uptake.

• An H/M ratio $\ge 1.6$ may help identify patients with lower one- and two-year mortality risks.

Exam Tip: mIBG Administration When administering I-123 mIBG (standard dose of 10 mCi), patients should be pre-medicated with SSKI. Note that mIBG is used for risk stratification and sympathetic assessment, but it is not indicated for selecting therapeutic interventions or monitoring treatment response.